Literature DB >> 9188596

Hemagglutinin-esterase, a novel structural protein of torovirus.

L A Cornelissen1, C M Wierda, F J van der Meer, A A Herrewegh, M C Horzinek, H F Egberink, R J de Groot.   

Abstract

We have characterized the 3'-most 3 kb of the genome of bovine torovirus (BoTV) strain Breda. A novel 1.2-kb gene, located between the genes for the membrane and nucleocapsid proteins, was identified. This gene, the 3'-most 0.5 kb of which is also present in the genome of the equine torovirus isolate Berne virus (BEV), codes for a class I membrane protein displaying 30% sequence identity with the hemagglutinin-esterases (HEs) of coronaviruses and influenza C viruses. Heterologous expression of the BoTV HE gene yielded a 65,000-molecular weight N-glycosylated protein displaying acetylesterase activity. Serologic evidence indicates that the HE homolog is expressed during the natural infection and represents a prominent antigen. By using an antiserum raised against residues 13 to 130 of HE, the HE protein was detected in radioiodinated, sucrose gradient-purified BoTV preparations. Formal evidence that HE is a structural protein was provided by immunoelectron microscopy. In addition to the large, 17- to 20-nm spikes, BoTV virions possess shorter surface projections (6 nm on average). We postulate that these surface projections, which are absent from the BEV virion, are composed of the BoTV HE homolog. The HE gene, which has now been demonstrated in three different virus genera, is a showpiece example of modular evolution.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9188596      PMCID: PMC191764          DOI: 10.1128/JVI.71.7.5277-5286.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  Surface proteins of Breda virus.

Authors:  M Koopmans; J Ederveen; G N Woode; M C Horzinek
Journal:  Am J Vet Res       Date:  1986-09       Impact factor: 1.156

3.  The glycoprotein of influenza C virus is the haemagglutinin, esterase and fusion factor.

Authors:  G Herrler; I Dürkop; H Becht; H D Klenk
Journal:  J Gen Virol       Date:  1988-04       Impact factor: 3.891

4.  Structural proteins of bovine coronavirus and their intracellular processing.

Authors:  D Deregt; M Sabara; L A Babiuk
Journal:  J Gen Virol       Date:  1987-11       Impact factor: 3.891

5.  The influenza C virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities.

Authors:  R Vlasak; M Krystal; M Nacht; P Palese
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

6.  Characterization and isolation of structural polypeptides in haemagglutinating encephalomyelitis virus.

Authors:  P E Callebaut; M B Pensaert
Journal:  J Gen Virol       Date:  1980-05       Impact factor: 3.891

7.  A morphological study of the replication of Breda virus (proposed family Toroviridae) in bovine intestinal cells.

Authors:  J A Fagerland; J F Pohlenz; G N Woode
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

8.  Morphological and biological properties of a new coronavirus associated with diarrhea in infant mice.

Authors:  K Sugiyama; Y Amano
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

9.  Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses.

Authors:  R Vlasak; W Luytjes; W Spaan; P Palese
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 10.  The proposed family Toroviridae: agents of enteric infections. Brief review.

Authors:  M Weiss; M C Horzinek
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

View more
  46 in total

Review 1.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

Review 2.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

3.  Expression of hemagglutinin esterase protein from recombinant mouse hepatitis virus enhances neurovirulence.

Authors:  Lubna Kazi; Arjen Lissenberg; Richard Watson; Raoul J de Groot; Susan R Weiss
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  Luxury at a cost? Recombinant mouse hepatitis viruses expressing the accessory hemagglutinin esterase protein display reduced fitness in vitro.

Authors:  A Lissenberg; M M Vrolijk; A L W van Vliet; M A Langereis; J D F de Groot-Mijnes; P J M Rottier; R J de Groot
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 5.  Virus maturation by budding.

Authors:  H Garoff; R Hewson; D J Opstelten
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Identification and characterization of a porcine torovirus.

Authors:  A Kroneman; L A Cornelissen; M C Horzinek; R J de Groot; H F Egberink
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  VI, 1. Epidemiology of toroviruses.

Authors:  Martin Petric
Journal:  Perspect Med Virol       Date:  2004-09-14

8.  Identification and characterization of genetically divergent members of the newly established family Mesoniviridae.

Authors:  Florian Zirkel; Hanna Roth; Andreas Kurth; Christian Drosten; John Ziebuhr; Sandra Junglen
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

Review 9.  Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.

Authors:  Yuhang Wang; Matthew Grunewald; Stanley Perlman
Journal:  Methods Mol Biol       Date:  2020

10.  Phylogenetic and evolutionary relationships among torovirus field variants: evidence for multiple intertypic recombination events.

Authors:  S L Smits; A Lavazza; K Matiz; M C Horzinek; M P Koopmans; R J de Groot
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.